Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre.

about

Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre.

Item

http://www.wikidata.org/entity/Q47920373

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Effect of CYP3A5 polymorphism ...... experience at a single centre.

@en

Effect of CYP3A5 polymorphism ...... experience at a single centre.

@nl

type

Item

label

Effect of CYP3A5 polymorphism ...... experience at a single centre.

@en

Effect of CYP3A5 polymorphism ...... experience at a single centre.

@nl

prefLabel

Effect of CYP3A5 polymorphism ...... experience at a single centre.

@en

Effect of CYP3A5 polymorphism ...... experience at a single centre.

@nl

P1476

Effect of CYP3A5 polymorphism ...... experience at a single centre.

@en

P2093

H Li

http://www.w3.org/2001/XMLSchema#string

H Liu

http://www.w3.org/2001/XMLSchema#string

J Yu

http://www.w3.org/2001/XMLSchema#string

L Yang

http://www.w3.org/2001/XMLSchema#string

N Zhao

http://www.w3.org/2001/XMLSchema#string

T Xu

http://www.w3.org/2001/XMLSchema#string

Y Cheng

http://www.w3.org/2001/XMLSchema#string

Y Liu

http://www.w3.org/2001/XMLSchema#string

Y Meng

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients

Pharmacogenomics--drug disposition, drug targets, and side effects.

The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks.

The effect of CYP3A5 6986A>G and ABCB1 3435C>T on tacrolimus dose-adjusted trough levels and acute rejection rates in renal transplant patients: a systematic review and meta-analysis.

Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients.

Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients.

Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.

P304

16-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJCP.12662

http://www.w3.org/2001/XMLSchema#string

P433

183

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26177012

http://www.w3.org/2001/XMLSchema#string